Skip to search formSkip to main contentSkip to account menu

Larix sp. WSU-cult

Known as: Larix sp. MJZ-2002 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Development of a Novel Small Molecule CRM-1 Inhibitor for Non Hodgkin's Lymphoma
Abstract 598 Recent evidence demonstrates that Non Hodgkin9s Lymphoma (NHL) tumors have elevated expression of the XPO1 gene that… 
2002
2002
Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
The t(14;18) is present in 85-90% of follicular lymphomas. It results in overexpression of the Bcl-2 protein, which inhibits… 
Highly Cited
2000
Highly Cited
2000
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
The incidence of non-Hodgkin's lymphoma has been increasing at a rate of 4% per year since 1950; more than 62,000 cases will be… 
2000
2000
Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines
Combretastatin A-4 (CA-4) is one of a family of compounds isolated from the South African willow tree Combretum caffrum. CA-4 was… 
1999
1999
Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines.
1995
1995
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.
The BCL-2 gene product is involved in preventing apoptosis. The t(14,18) chromosomal translocation, which results in a fusion… 
Highly Cited
1994
Highly Cited
1994
Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.
The immunomodulating effects and antitumor activity of two biological agents, bryostatin 1 (Bryo1) and alpha-interferon, were… 
1993
1993
A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11).
1993
1993
Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
1992
1992
A human B‐cell lymphoma line with a de novo multidrug resistance phenotype
A human diffuse large cell lymphoma line (WSU‐DLCL) expressing multidrug resistance (MDR) was established from a patient with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)